Clinical, Imaging, and Disease Progression Sex-related Differences in Transthyretin Cardiac Amyloidosis
Revista Argentina de Cardiologia · 21.04.2026 · 94 (2) · 120-126
DOI: 10.7775/rac.v94.i2.20989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Argentina de Cardiologia, online erschienen am 21.04.2026. Verfasst von Santiago Decotto und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly diagnosed disease. Sex-related differences in clinical presentation and disease progression have been described; however, we lack local data identifying these differences.
Objective
The aim of this study was to describe sex-related differences in clinical presentation, imaging characteristics at diagnosis, and disease progression in patients diagnosed with ATTR-CA.
Methods
A retrospective, multicenter (two centers) cohort study was conducted including patients diagnosed with ATTR-CA be-tween 2010 and 2025. Clinical, electrocardiographic, and imaging variables at the time of diagnosis, as well as events during follow-up, were obtained from institutional electronic medical records. Baseline characteristics were compared between men and women using appropriate statistical tests. Kaplan-Meier curves were built to estimate the incidence of all-cause mortality, hospitalizations for heart failure, and a composite endpoint of both events.
Results
A total of 186 patients were included: 153 men (82.2%) and 33 women (17.8%). Women were diagnosed at an older age (83 vs. 80 years; p=0.042) and had thinner septal and posterior wall thicknesses (14.8 vs. 16.9 mm; p=0.020 and 12.7 vs. 14.3 mm; p=0.005, respectively) on baseline echocardiography compared with men. On cardiac magnetic resonance imaging (n=108), women had higher left and right ventricular ejection fractions (62% vs. 50%; p=0.031 and 56% vs. 47%; p=0.011, respectively) and lower maximum wall thickness (16.4 mm vs. 18.7 mm; p=0.013). During a median follow-up of 725.5 days (interquartile range, IQR, 342.5–1220), no statistically significant differences in mortality or hospitalizations for heart failure were observed between the two sexes.
Conclusions
In this national cohort of patients with ATTR-CA, women were diagnosed at an older age and had less structural and functional myocardial involvement at the time of diagnosis. However, these differences did not translate into a significant impact on clinical outcomes during follow-up.
Zitieren
APA
Decotto, S., Cantora, F., Domenech, P., Touzas, P., Blanco, R., Aguirre, M. A., Carretero, M., Bruic, E., Nucifora, E., Martínez, M. L. P., Pizarro, R., & Arenaza, D. P. D. (2026). Clinical, Imaging, and Disease Progression Sex-related Differences in Transthyretin Cardiac Amyloidosis. Revista Argentina de Cardiologia, 94(2), 120-126. https://doi.org/10.7775/rac.v94.i2.20989
Vancouver
Decotto S, Cantora F, Domenech P, Touzas P, Blanco R, Aguirre MA, et al. Clinical, Imaging, and Disease Progression Sex-related Differences in Transthyretin Cardiac Amyloidosis. Revista Argentina de Cardiologia. 2026;94(2):120-126. doi:10.7775/rac.v94.i2.20989
BibTeX
@article{Decotto2026,
author = {Decotto, Santiago and Cantora, Florencia and Domenech, Pilar and Touzas, Pedro and Blanco, Rocío and Aguirre, María Adela and Carretero, Marcelina and Bruic, Erica and Nucifora, Elsa and Martínez, María Lourdes Posadas and Pizarro, Rodolfo and Arenaza, Diego Pérez de},
title = {Clinical, Imaging, and Disease Progression Sex-related Differences in Transthyretin Cardiac Amyloidosis},
journal = {Revista Argentina de Cardiologia},
year = {2026},
volume = {94},
number = {2},
pages = {120--126},
doi = {10.7775/rac.v94.i2.20989}
}
EUVIMED